Editorial
How to identify better candidate to radioembolization in case of hepatocellular carcinoma and portal vein tumoral thrombosis
Abstract
Hepatocellular carcinoma (HCC) is the most common primary liver cancer and the fifth most common malignant tumor worldwide. Liver resection is a curative treatment for HCC and can be safety performed by a minimally invasive procedure in all liver segments without size limitations (1,2).